Early Look

Tuesday, August 18, 2026

Futures

Up/Down

%

Last

Dow

17.00

0.03%

53,561

S&P 500

-35.25

0.46%

7,733

Nasdaq

-358.50

1.19%

29,737

 

 

U.S. stock futures, particularly technology stocks (QQQ), retreated overnight as long-term borrowing costs from the United States to Japan and Germany rose to their highest levels in decades as Brent oil prices rose back above $90 a barrel, fanning inflation worries as U.S.-Iran peace hopes faded. Oil prices rose for a third session Monday as prospects receded for a deal to end the Middle East war, with Iran saying it would adopt a more offensive stance and the U.S. ruling out extending a ceasefire deal, heightening worries about energy supply. The 30-year yield climbs above 5.32% (new 19 year highs) while the benchmark 10-year tops 4.73% adding to fears. Wall Street is coming off modest losses as energy (XLE) was a leader Monday as WTI and Brent settled up 2.6% and 2.7%, respectively, and both chips (SOX) and metals outperformed…but consumer staples, REITs, large cap tech, travel and leisure were among the biggest losers. Today, housing data is on tap, with housing starts, building permits and pending home sales on the docket as well as Industrial production and import/export prices. In Asian markets, The Nikkei Index tumbled -1,759 points or 2.54% to settle at 67,460, the Shanghai Index rose 7 points to 3,990, and the Hang Seng Index advanced 17 points to 25,471. In Europe, the German DAX is down -87 points to 26,251, while the FTSE 100 is up a few points to 10,722.

 

Market Closing Prices Yesterday

  • The S&P 500 Index slumped -40.42 points, or 0.52%, to 7,745.35
  • The Dow Jones Industrial Average fell -272.51 points, or 0.51%, to 53,460.02
  • The Nasdaq Composite dropped -84.25 points, or 0.32%, to 26,644.91
  • The Russell 2000 Index declined -10.88 points, or 0.35% to 3,057.53

Economic Calendar for Today

  • 7:45 AM ET ICSC Weekly Retail Sales
  • 8:30 AM ET                   Housing Starts M/M for July…est. 1.35M
  • 8:30 AM ET                   Building Permits M/M for July…est. 1.37M
  • 8:30 AM ET                   Import Prices M/M for July…est. +0.1%
  • 8:30 AM ET                   Export Prices M/M for July…est. +0.2%
  • 8:55 AM ET                   Johnson/Redbook Weekly Sales
  • 9:15 AM ET                   Industrial Production M/M for July…est. +0.3%
  • 9:15 AM ET                   Capacity Utilization for July…est. 76.3%
  • 10:00 AM ET                 Pending Home Sales M/M for July…est. +0.3%
  • 4:30 PM ET API Weekly Inventory Data

Earnings Calendar:

  • Earnings Before the Open: AS BIDU EVGN HD HSAI IQ KLAR PONY PRE UCL VNET
  • Earnings After the Close: AUNA JKHY KEYS LZB MRCY SQM TOL ZTO

Other Key Events:

  • Needham 15th annual Virtual Industrial Tech Robotics & Power 1x1 Conference, 8/18-8/18
  • Piper California Medtech & Diagnostics Bus Tour, 8/18-8/20
  • Rosenblatt 6th Annual Age of AI Tech Virtual Summit, 8/17-8/18
  • Seaport Global 15th Annual Summer Investor Virtual Conference, 8/18-8/19

 

 

Macro

Up/Down

Last

Nymex

0.23

91.10

Brent

0.48

84.98

Gold

-23.20

4,450.50

EUR/USD

-0.0005

1.1574

JPY/USD

0.25

159.68

10-Year Note

+0.01

4.735%

 

World News

  • German ZEW Indicator of Economic Sentiment for Germany--which tracks the expectations of 185 analysts and investors at banks, insurance companies and other businesses--rose to 34.2 in August compared with 26.3 in July. But while that was the fourth rise in the barometer in as many months, but the reading was below that in February.
  • Britain's labor market cooled further in Q2, marked by slowing earnings growth in the private sector. Private sector regular earnings rose by 2.8% in annual terms during the three months to June, marking the weakest growth since the three months to October 2020.
  • U.S. June net overall capital flow +$133.5B vs +$131.5B in May (vs. prior +$132.2B); U.S. June net long-term flow (ex-swaps/other) +$172.7B vs +$231.2B in May; U.S. June net official capital flow +$48.4B vs (-$39.9B in May); Japan's U.S. Treasury holdings $1.117 trln in June vs $1.143 trln in May and China holdings $633B in June vs $659B in May.

Sector News Breakdown

Consumer

  • Home Depot (HD) Q2 Sales rose 5.7% y/y to $47.86B vs. est. $47.27B; Q2 adj. EPS $4.92 vs. est. $4.73; Q2 Comparable Sales +1.7% vs. est. +0.7%; Q2 net income $4.8B vs. est. $4.72B; reaffirms fiscal 2026 guidance, including total sales growth of 2.5% to 4.5% and expects FY26 comparable sales growth of flat to 2.0% and sees fiscal 2026 diluted EPS growth of flat to 4.0% from $14.23 in fiscal 2025
  • Amer Sports (AS) Q2 revenue rose 32% y/y to $1.63B topping est. $1.54B, while adjusted EPS for Q2 rose $0.18; raises full-year 2026 revenue growth guidance to about 24% and now sees 2026 gross margin at 60.5–61.0% and operating margin at 14.2–14.5%; said strong Q2 revenue growth was driven by Technical Apparel, Outdoor Performance, and Ball & Racquet (Wilson Tennis 360).
  • Costco (COST) plans to soon rollout Costco-branded Medicare plans, working with SCAN Group, Anna the Wall Street Journal reports. The two companies would start selling their jointly named Medicare Advantage in two states and a Medicare supplement in a third state.

Energy, Industrials and Materials

  • Firefly Aerospace (FLY) onboarded to NASA spacecraft processing operations contract; eligible to provide payload processing, fueling, integration, and encapsulation for NASA missions.
  • Flexsteel Industries (FLXS) says consumer demand for furniture remains pressured by macroeconomic uncertainty related to ongoing conflict in Middle East; Q4 adj EPS $1.33 vs est $1.09 on revs $115.365Mm vs est $109.66Mm, gr mgn 30%; guides Q1 revs $111-115Mm vs est $106.8Mm.
  • Kaiser Aluminum (KALU) announced a leadership transition, with the Board of Directors appointing Fred Stephan as Chief Executive Officer and President, effective November 1, 2026, as part of its long-term succession planning process.
  • Targa Resources (TRGP) said it signed new 20-year fee-based agreements with Exxon Mobil (XOM) to provide integrated natural-gas gathering, processing, and downstream services in the Permian Basin and plans to build three new processing plants in the region.

Financials

  • Nasdaq reveals it will launch a new 9 p.m. to 4 a.m. ET trading session on December 6 as it moves toward nearly continuous 23-hour trading, five days a week.
  • Aon Plc (AON) CFO Edmund Reese will transition from his role as EVP and CFO effective immediately, to pursue opportunities outside the firm. Aon appointed Nadin Virani as Interim CFO, effective immediately, and Reese will serve as senior advisor to Aon President and CEO Greg Case, through August 16, 2027
  • XP Inc. (XP) Q2 adjusted net profit R$1.38B vs. est. R$1.37B; gross revenue R$5.06B, +8% YoY; total client assets R$2.2T; 11.79Mm Class A Treasury shares to be cancelled.

Healthcare

  • DocGo (DCGO) Q2 revs fell -8.7% y/y to $73.4M vs. est. $75.4M; Q2 Net loss widened to -$18M and adj EBITDA loss was -$6.3M, little changed y/y; Medical Transportation Services revenue rose to $52M and Mobile Health Services revenue fell to $21.4M due to no migrant-program revenue; agreed to acquire Hicuity Health, assuming about $52M of Perceptive Advisors debt; 2026 revenue outlook narrowed to $305-$310M.

Technology, Media & Telecom

  • Baidu (BIDU) Q2 revs fell -4% y/y to RMB31.33B vs. est. RMB31.96; said Q2 revenue from AI Cloud Infra rose 50% y/y, driven by mounting demand for public cloud-based AI computing; Revenue from AI Applications increased 3% yr/yr, reflecting only modest expansion; online marketing services segment reported total revenue of 13.1B yuan in Q2, down -19% from a year ago.
  • Duos Technology Group (DUOT) Q2 EPS $1.35 vs est $0.66; revenue $6.18Mm vs est $4.9Mm, +30% YoY; operating Income $49k; FY revenue guidance over $50Mm vs est $55.5Mm; 25 MW deployed target reaffirmed.
  • Fabrinet (FN) Q4 adj EPS $4.10 vs. est. $3.82; Q4 revs rose 45% y/y to a record $1.316B vs. est. $1.275B and adj net income $149.1M vs. est. $138.7M; guides Q1 revs $1.375-$1.42B vs. est. $1.321B and EPS $4.10-$4.25 vs. est. $3.98.
  • Meta (META) will face off against attorneys general from several states in an Oakland, Calif., courtroom Tuesday as part of a major lawsuit alleging that the company violated child safety and consumer protection laws and harmed children's mental health.
  • Xiaomi (XIACY) said it expects memory price increase to slow down in 2H

Mid-Morning Look

Tuesday, August 18, 2026

Index

Up/Down

%

Last

DJ Industrials

-15.94

0.03%

53,439

S&P 500

-38.34

0.50%

7,706

Nasdaq

-342.33

1.28%

26,302

Russell 2000

-20.03

0.65%

3,037

 

 

U.S. stock markets open lower as the names that were higher on Monday such as semiconductors (SOX), data centers and precious metals are seeing early weakness, while defensive sectors such as Consumer Staples, Healthcare and REITs are rallying in another sector rotation, and Energy outperforms as oil prices hit highest levels in weeks. Global bond yields surged to multi-decade highs as expiring U.S.-Iran ceasefire talks collapse, pushing oil prices higher and stoking fresh inflation fears. President Trump said on social media today, "There are no talks or conversations going on, or scheduled, with the Islamic Republic of Iran. The Naval Blockade remains in full force and effect. The Hormuz Strait is open and operating. All Water mines have been removed or detonated.” A day after the PHLX Semi Index (SOX) topped its 50dma resistance of roughly 12585, the index falls notable this morning -5.2% to below 12,000 in strong pullback for semis/AI space. At the same time, investors rotate back into software names and some hyperscalers which fell Monday.

 

Higher oil and rising Treasury yields the past few sessions is what is moving markets lower (after the S&P 500, Dow Jones Industrial Average and the Russell 2000 hit record highs recently) as front month Brent crude oil rose 2.5% on Monday to $91 per barrel, highest since July 24 though only minimal gains today despite reports of another attack on a ship near Oman. WTI is tracking higher around $85 per barrel after the squeeze yesterday on reports that Iran has seized a UAE-owned tanker in the Strait. President Trump’s threat to attack Oman added to concerns along with data showing shipping has slowed dramatically in the Strait of Hormuz with fewer ships passing through. The 30-yr hit fresh 19 year highs above 5.34% this morning and the 10-yr above 4.74% but have since pulled back off highs and edged lower.

 

Economic Data

  • July Housing Starts fell -12.4% to 1.239M unit rate, well below the consensus 1.350M; July single-family starts -9.9% to 808,000 unit rate; multifamily -16.8% to 431,000 unit rate. July housing permits rose +5.0% to 1.443M unit rate (consensus 1.370M) vs June 1.374M unit rate vs. June (-2.6%). July single-family permits +2.5% to 894,000 unit rate; multifamily +9.4% to 549,000 unit rate.
  • Import prices fell (-0.4%) in July, versus +0.1% expected while July export prices fell (-1.3%) vs. consensus +0.2% and vs June (-0.7%). July y/y import prices rose +5.9% (down from +7.1%), while export prices rose +8.2% (down from +10.2% m/m). U.S. July non-petroleum import prices +0.3%, year-over-year +4.5% and July Petroleum import prices (-7.5%) vs June (-4.3%).
  • July Industrial Capacity Utilization reported at 76.3% (in line with expected) while June was revised up to 76.2% from 76.1%; Manufacturing capacity utilization: 76.0% (up from 75.7% in June, +30 bps). July Industrial Output +0.2% (vs. consensus +0.3%) vs June +0.3%.
  • July Pending Home sales -2.2% from July 2025 while U.S. July Pending Home sales index -2.3% (consensus +0.3%) to 71.2.
  • The US Treasury International Capital report for June showed total net TIC flows of $133.5B (prior: $131.5B) and net long-term flows of $172.7B (prior: $231.2B). The headline was broadly stable month-on-month, but the $60bn deceleration in long-term flows was the standout.
  • Total foreign holdings of US treasury fell $72.1B in June — the largest single-month decline since March's $134.4B plunge and the second largest of 2026.

 

 

Macro

Up/Down

Last

WTI Crude

0.46

84.20

Brent

0.09

90.96

Gold

-20.20

4,451.50

EUR/USD

0.0002

1.1580

JPY/USD

0.20

159.57

10-Year Note

-0.006

4.718%

 

Sector Movers Today

  • Opticals, Photonics & Networking: FN quarterly results beat on top and bottom line, largely on DCI strength while Datacom and HPC missed estimates again in FQ4; new capacity on track and new programs ramping to fuel growth in FY27 and beyond; now has four 10% customers, up from two y/y; shares of the optical sector, which has surged massively the last few trading days (AAOI, COHR, LITE, CIEN) took a notable pullback today.
  • In REITs: Keybanc changes in Retail REITs, upgrading AKR to Overweight from Sector Weight ($25 PT) and downgrading KRG to Sector Weight from Overweight. AKR's YTD underperformance (+3.4%, -1,480 bps vs. Shopping Center REITs and -1,520 bps vs. the RMS) has created an attractive entry point as visibility improves around several earnings growth drivers. REXR agreed to sell a portfolio of 22 industrial properties to an affiliate of EQT Real Estate for about $1.2 billion, part of its $2 billion plan to dispose of non-core assets and recycle capital.

 

Stock GAINERS

  • AMLX +47%; announces positive topline results from phase 3 LUCIDITY clinical trial of Avexitide in post-bariatric hypoglycemia; LUCIDITY met FDA-agreed-upon primary endpoint; avexitide demonstrated a 55% reduction in the composite rate of Level 2 and Level 3 hypoglycemic events compared to placebo (p=0.000003); LUCIDITY also met all secondary endpoints
  • AS +3%; Q2 revenue rose 32% y/y to $1.63B topping est. $1.54B, while adjusted EPS for Q2 rose $0.18; raises full-year 2026 revenue growth guidance to about 24% and now sees 2026 gross margin at 60.5–61.0% and operating margin at 14.2–14.5%.
  • BBWI +5%; upgraded to Buy at Citigroup saying believes the combination of a Q2 EPS beat, positive tone about recent product launches, and potential upside to estimates from energy prices/tariff refunds, along with a depressed stock price creates a very attractive risk/reward.
  • DUOL +5%; was upgraded to Buy from Neutral at DA Davidson with $160 tgt saying the company’s product enhancements, marketing changes and continued monetization improvements are underappreciated by investors as sees a long runway for growth in coming years.
  • FLXS +13%; says consumer demand for furniture remains pressured by macroeconomic uncertainty related to ongoing conflict in Middle East; Q4 adj EPS $1.33 vs est $1.09 on revs $115.365Mm vs est $109.66Mm, gr mgn 30%; guides Q1 revs $111-115Mm vs est $106.8Mm.
  • HAE +14%; disclosed a non-exclusive agreement in which CSL Pharma may utilize the company sNExSys PCS devices with Persona PLUS technology and related disposables in the US.
  • TRGP +6%; shares were strong after the company announced a major expansion of its strategic relationship with XOM in the Permian Basin. Goldman Sachs said views the agreements as a significant positive for Targa's long-term growth outlook.
  • WEAV +31%; as Francisco Partners announced that FP has entered into a definitive agreement to acquire Weave, at an aggregate equity valuation of approximately $650M. Under the terms of the agreement, Weave stockholders will receive $7.40 per share in cash

 

Stock LAGGARDS

  • ATHM -5%; was downgraded to Underperform at Bank America saying the company is facing significant earnings pressure from auto industry headwinds and its business transition, and notes Autohome has weaker financials and higher industry risk vs other China online vertical platforms.
  • BIDU -8%; after Q2 revs fell -4% y/y to RMB31.33B vs. est. RMB31.96; said Q2 revenue from AI Cloud Infra rose 50% y/y, driven by mounting demand for public cloud-based AI computing; Q2 revs from AI applications increased 3% y/y; online marketing services segment revs of 13.1B yuan down -19% y/y.
  • DCGO -25%; 2Q revenue/EBITDA below consensus while 2026 revenue guidance maintained, though EBITDA loss increased. Continues to target breakeven EBITDA exiting 2026.
  • FN -18%; quarterly results beat on top and bottom line, largely on DCI strength while Datacom and HPC missed estimates again in FQ4 according to Barclay’s; new capacity on track and new programs ramping to fuel growth in FY27 and beyond.
  • KLAR -20%; announces planned CFO/CMO transitions, Q2 results better ww/smaller net profit loss y/y of -$9M, revs rose 27% to $1.04B (est. $994M) and GMV rose 18% to $36.6B but lowers FY26 revenue view $4.08B-$4.16B from over $4.34B (est. $4.42B) and sees FY GMV $149B-$151B, down from prior view of greater than $155B.

Closing Recap

Tuesday, August 18, 2026

Index

Up/Down

%

Last

DJ Industrials

-116.14

0.22%

53,343

S&P 500

-53.09

0.69%

7,691

Nasdaq

-355.20

1.33%

26,289

Russell 2000

-39.66

1.30%

3,017

 

 

 

 

 

 

 

 

 

U.S. stocks ended lower for a third consecutive day, as the tech heavy Nasdaq Composite underperformed, dragged down by a sell-off in semiconductors as the SOX fell as much as 6% this morning, back below key technical levels after jumping the day prior while Smallcaps also faltered. The combination of a run in Treasury yields to multi year highs coupled with oil prices at multi week highs was enough to damage broader markets with light volumes in August summer trading. Chances of a Fed rate hike at the September meeting have dwindled in recent days following several weaker economic data reports including a decline in monthly jobs, weaker retail sales and cooler CPI/PPI inflation, yet, the 30-year Treasury yield touched 5.3371%, highest level since 2007 this morning before paring back. The Nasdaq fell over 1% as Treasury yields pressure rate-sensitive technology stocks, as data center, semis and AI names tumbled. Attention turns back to retailers tomorrow morning with earnings from Target (TGT), Lowe’s (LOW), and TJ Maxx (TJX). Precious metals fell, Bitcoin bounced, the dollar was flattish, oil rose and Treasury yields ended lower.

Economic Data

  • July Housing Starts fell -12.4% to 1.239M unit rate, well below the consensus 1.350M; July single-family starts -9.9% to 808,000 unit rate; multifamily -16.8% to 431,000 unit rate. July housing permits rose +5.0% to 1.443M unit rate (consensus 1.370M) vs June 1.374M unit rate vs. June (-2.6%). July single-family permits +2.5% to 894,000 unit rate; multifamily +9.4% to 549,000 unit rate.
  • Import prices fell (-0.4%) in July, versus +0.1% expected while July export prices fell (-1.3%) vs. consensus +0.2% and vs June (-0.7%). July y/y import prices rose +5.9% (down from +7.1%), while export prices rose +8.2% (down from +10.2% m/m). U.S. July non-petroleum import prices +0.3%, year-over-year +4.5% and July Petroleum import prices (-7.5%) vs June (-4.3%).
  • July Industrial Capacity Utilization reported at 76.3% (in line with expected) while June was revised up to 76.2% from 76.1%; Manufacturing capacity utilization: 76.0% (up from 75.7% in June, +30 bps). July Industrial Output +0.2% (vs. consensus +0.3%) vs June +0.3%.
  • July Pending Home sales -2.2% from July 2025 while U.S. July Pending Home sales index -2.3% (est. +0.3%) to 71.2.
  • The US Treasury International Capital report for June showed total net TIC flows of $133.5B (prior: $131.5B) and net long-term flows of $172.7B (prior: $231.2B). The headline was broadly stable month-on-month, but the $60bn deceleration in long-term flows was the standout.
  • Total foreign holdings of US treasury fell $72.1B in June — the largest single-month decline since March's $134.4B plunge and the second largest of 2026.

Commodities

  • Gold prices fell as Treasury yields surged to their highest levels in decades, with rising energy prices on escalating U.S.-Iran tensions further stoking inflation worries and weighing on non-interest-bearing bullion. December gold declined -$53.10, or -1.19%, to settle at $4,420.60 an ounce while September Silver dropped -$2.19, or -3.31%, to finish at $64.04 an ounce. Prices failed to bounce despite Treasury yields finishing off their high with a midday move lower. Long-term borrowing costs from the U.S. to Japan and Germany hit their highest levels in decades, weighing on non-yielding gold, while crude prices remained in positive territory.
  • Oil prices were slightly higher, gaining for a third straight session, with WTI crude oil rising $0.44 or 0.52% to settle at $84.94 per barrel and Brent crude edges higher $0.15 or 0.17% to $91.02 per barrel as prospects for a U.S.-Iranian peace deal dimmed after Tehran said it would adopt a more offensive stance and Washington ruled out extending a ceasefire deal.

Currencies & Treasuries

  • Treasury yields have hit multi-year highs, but took a small breather today…are highs in? The sharp increase in U.S. Treasury yields, with 30-year yields hitting their highest since 2007, comes despite recent weaker economic data reducing expectations for an imminent Federal Reserve interest-rate hike. Additionally, heavy government borrowing and growing competition for capital, including debt issuance associated with the AI investment boom, are lifting longer-term borrowing costs. At the same time, the national debt is expected to top $40 trillion by the end of August, more than double decade-ago levels. The yield on the U.S. 30-year Treasury bond was last down 2.32 basis points at 5.2868%, after reaching 5.3371%, the highest since 2007. Benchmark 10-year note yields fell 1.6 basis points to 4.708% and got to 4.7478%, the highest since January 2025.

 

Macro

Up/Down

Last

WTI Crude

0.44

84.94

Brent

0.15

91.02

Gold

-53.10

4,420.60

EUR/USD

-0.0004

1.1575

JPY/USD

0.16

159.59

10-Year Note

-0.016

4.708%

 

Sector News Breakdown

Retail, Consumer Staples & Restaurants:

  • Home Improvement retail: Dow component HD reported Q2 sales +5.7% y/y to $47.86B vs. est. $47.27B; Q2 adj. EPS $4.92 vs. est. $4.73; Q2 Comparable Sales +1.7% vs. est. +0.7%; Q2 net income $4.8B vs. est. $4.72B; reaffirms fiscal 2026 guidance, including total sales growth of 2.5% to 4.5% and expects FY26 comparable sales growth of flat to 2.0%. LOW set to report earnings tomorrow morning.
  • Sporting Goods retail: AS Q2 revenue rose 32% y/y to $1.63B topping est. $1.54B, while adjusted EPS for Q2 rose $0.18; raises full-year 2026 revenue growth guidance to about 24% and now sees 2026 gross margin at 60.5–61.0% and operating margin at 14.2–14.5%; said strong Q2 revenue growth was driven by Technical Apparel, Outdoor Performance, and Ball & Racquet (Wilson Tennis 360).
  • Apparel Retail: ANF was downgraded at Raymond James to Market Perform from Outperform citing valuation with the shares up 25% since the Q1 results as the firm sees a balanced risk/reward with the stock around $105; expects Abercrombie same-store sales to remain mixed. Beaten up retailers LULU and NKE saw notable gains today – still big decliners on year (LULU down -42% YTD and NKE -36.5% YTD).
  • Hardline/Warehouse retail: COST plans to soon rollout Costco-branded Medicare plans, working with SCAN Group, the Wall Street Journal reports. The two companies would start selling their jointly named Medicare Advantage in two states and a Medicare supplement in a third state. TGT reports tomorrow morning.
  • Specialty Retail: BBWI was upgraded to Buy at Citigroup saying believes the combination of a Q2 EPS beat, positive tone about recent product launches, and potential upside to estimates from energy prices/tariff refunds, along with a depressed stock price creates a very attractive risk/reward.

Autos, Leisure, Gaming & Lodging:

  • Cruise sector: NCLH was downgraded from Outperform to Neutral at Mizuho and cut its tgt to $17 from $22 saying Norwegian is in the midst of a turnaround, in part resulting from Self-inflicted wounds (accelerated supply, change in customer segmentation, delays in construction, changes to personnel and adjustments to the booking-curve), as well as macro headwinds.
  • Auto sector: ATHM was downgraded to Underperform at Bank America saying the company is facing significant earnings pressure from auto industry headwinds and its business transition, and notes Autohome has weaker financials and higher industry risk vs other China online vertical platforms.  CVNA shares were notably weaker as the WSJ reported worries swirling that a federal investigation into one of its investors, Mark Walter, could lead to the billionaire selling his stake of the used car retailer.

Energy, Industrials and Materials

  • MLPs/Pipelines: TRGP shares were strong after the company announced a major expansion of its strategic relationship with XOM in the Permian Basin. Goldman Sachs said views the agreements as a significant positive for Targa's long-term growth outlook, increasing visibility into volume growth, market share gains, and downstream infrastructure utilization through the end of the decade. OKE, PR, MPC, VLO, TRGP, TDW, SM, DINO, HP, ET, CVE, NOV were among energy stocks hitting 52-week highs today.
  • Utility/Solar sector: NEE extends its winning streak to 8 days (approaching its 50dma of $87.15); UGI shares jumped after the WSJ reported late morning that the natural gas and electricity distributor recently received a roughly $9B takeover offer from KKR. https://tinyurl.com/y3kv6t62
  • Machinery & Equipment: TAYD Q4 sales fell sharply y/y to $8.95M due to delayed customer orders (est. $12.8M) as Q4 net income and EPS declined from prior year, reflecting lower sales volume; ended FY26 with record $52.8M firm order backlog, led by Aerospace/Defense. IR shares remain weak, falling for a 9th straight day as dips below its 200dma support $81.95.
  • Industrial Metals sector: FLXS says consumer demand for furniture remains pressured by macroeconomic uncertainty related to ongoing conflict in Middle East; Q4 adj EPS $1.33 vs est $1.09 on revs $115.365Mm vs est $109.66Mm, gr mgn 30%; guides Q1 revs $111-115Mm vs est $106.8Mm.

Financials

  • Payment sector: KLAR shares tumbled as Q2 results were better for smaller net profit loss y/y of -$9M, revs rose 27% to $1.04B (est. $994M) and GMV rose 18% to $36.6B but the company lowers FY26 revenue view $4.08B-$4.16B from over $4.34B (est. $4.42B) and sees FY GMV $149B-$151B, down from prior view of greater than $155B, driven by roughly $600M in currency translation.
  • Brokers & Banks: GS said it will buy commercial real estate investor LCN Capital Partners for as much as $410M, paying about $260M upfront for LCN, with a further potential payout of up to $150M tied to future performance targets and service commitments (about 80% will be paid in stock)
  • Crypto sector: Bitcoin and Ethereum have seen gains the last few days with Bitcoin rising to $65,750; The SEC today proposed new rules that would create "a clear and fit-for-purpose framework for certain investment contracts involving crypto assets," according to a news release.
  • Lending sector: U.S. auto loan delinquency 90+ days past due near 23-year high as debt reaches $1.713 Trillion (name sin auto lending to watch CVNA, OMF, ALLY, CACC).
  • Insurance sector: AON announced CFO Edmund Resse is leaving after 2 years to pursue opportunities outside AON. Nadin Virani Global head of Corp planning and analytics will serve interim CFO; affirmed FY'26 guide targeting 70-80bps adj margin expansion with mid-single digit + organic growth.
  • In REITs: Keybanc changes in Retail REITs, upgrading AKR to Overweight from Sector Weight ($25 PT) and downgrading KRG to Sector Weight from Overweight. AKR's YTD underperformance (+3.4%, -1,480 bps vs. Shopping Center REITs and -1,520 bps vs. the RMS) has created an attractive entry point as visibility improves around several earnings growth drivers. REXR agreed to sell a portfolio of 22 industrial properties to an affiliate of EQT Real Estate for about $1.2 billion, part of its $2 billion plan to dispose of non-core assets and recycle capital.

Healthcare

  • AMLX announces positive topline results from phase 3 LUCIDITY clinical trial of Avexitide in post-bariatric hypoglycemia; LUCIDITY met FDA-agreed-upon primary endpoint; avexitide demonstrated a 55% reduction in the composite rate of Level 2 and Level 3 hypoglycemic events compared to placebo (p=0.000003); LUCIDITY also met all secondary endpoints
  • BMRN said it has agreed to acquire privately held drug developer Alesta Therapeutics to gain access to ALE1, an experimental treatment for the rare genetic disorder hypophosphatasia; will pay $275M upfront and up to $215M in added payments tied to certain development and regulatory milestones.
  • Healthcare Services: DCGO 2Q revenue/EBITDA below consensus while 2026 revenue guidance maintained, though EBITDA loss increased. Continues to target breakeven EBITDA exiting 2026.
  • Dental sector: Piper noted ALGN Clear aligner volumes measured across Piper's data set of several hundred U.S. orthodontic offices declined 8.2% Y/y in July while teens were also down a similar amount (7.2%) and underperformed B&W by the widest margin of the year (8 points).
  • Medical Equipment sector: HAE disclosed a non-exclusive agreement in which CSL Pharma may utilize the company’s sNExSys PCS devices with Persona PLUS technology and related disposables in the US.

Semis, Internet, Media & Telecom

  • A day after the PHLX Semi Index (SOX) topped its 50dma resistance of roughly 12,585, the index falls notably this morning, as much as -6% to under 11,900 in strong pullback for semis/AI space (before ending only slightly better than that on the day). At the same time, investors rotate back into software names and some hyperscalers which fell Monday. Memory stocks SKHY, MU, SNDK saw the most notable pullbacks in the semi space after a huge run since the July selloff in what remains very volatile.
  • Internet/Online services; BIDU shares fell after Q2 revs fell -4% y/y to RMB31.33B vs. est. RMB31.96; said Q2 revenue from AI Cloud Infra rose 50% y/y, driven by mounting demand for public cloud-based AI computing; Revenue from AI Applications increased 3% y/y, reflecting only modest expansion; online marketing services segment reported total revenue of 13.1B yuan in Q2, down -19% y/y. DUOL was upgraded to Buy at Davidson with $160 tgt saying the company’s product enhancements, marketing changes and continued monetization improvements are underappreciated by investors as sees a long runway for growth in coming years.
  • Media Sector: The WSJ reported DIS ABC has sued the Federal Communications Commission (FCC) alleging the agency's efforts to challenge its Broadcast licenses and regulate its talk show "The View" are illegal and an effort to quash speech the Trump administration finds objectionable.

Hardware & Software movers:

  • Data Center/neoclouds: NBIS shares active after Vineland’s Planning Board approved Phase 2, adding 600,000 square feet to Nebius’ AI data center and clearing a key project hurdle. The approval removes a major execution risk for Nebius’ $17.4B MSFT cloud deal, which relies on capacity from the facility. AMZN to grow Louisiana data center investment from $12B to $18B with a third data center campus
  • Opticals, Photonics & Networking: FN quarterly results beat on top and bottom line, largely on DCI strength but shares tumbled as Datacom and HPC missed estimates again in FQ4; new capacity on track and new programs ramping to fuel growth in FY27 and beyond; now has four 10% customers, up from two y/y; shares of the optical sector, which has surged massively recently (AAOI, COHR, LITE, CIEN) saw a notable pullback today.
  • Software sector: a rebound for the group after broad weakness on Monday; WEAV shares jumped after Francisco Partners announced that FP has entered into a definitive agreement to acquire Weave, at an aggregate equity valuation of approximately $650M. Under the terms of the agreement, Weave stockholders will receive $7.40 per share in cash.
  • Handhelds & Telecom: Xiaomi (XIACY) Q2 Revenue fell -6.1% y/y to RMB108.92B vs. RMB115.96B; Q2 Gross Profit RMB21.61B vs. RMB26.10B y/y; Q2 basic EPS RMB0.37 vs. RMB0.46 y/y and H1 Revenue RMB208.06B vs. RMB227.25B y/y; said expects memory price increase to slow down in 2H; Q2 Smartphone revenue fell -7.5% y/y to RMB42.12B, while IoT and lifestyle products revenue declined 19.2% to RMB31.28B; Smart EV, AI and other new initiatives revenue increased 17.1% y/y.

Not offered or endorsed by Regal Securities

Street Recommendations

Tuesday, August 18, 2026

BARCLAYS

  • ELVN Barclays analyst Etzer Darout initiated coverage of Enliven with an Overweight rating and $78 price target. The company's ELVN-001 has a "best-in-class" active site tyrosine kinase inhibitor in chronic myeloid leukemia, the analyst tells investors in a research note. The firm says the space is seeing strategic interest.
  • CRWD Barclays raised the firm's price target on CrowdStrike to $235 from $169 and keeps an Overweight rating on the shares ahead of the Q2 report on August 26. The firm models CrowdStrike's new net annual recurring revenue of $285M, and sees an upside case of $300M-plus based on its "strong" channel checks. Crowdstrike will hold an analyst day at Fal.Con, "which could create a follow-through catalyst" for the shares, the analyst tells investors in a research note.
  • FN Barclays raised the firm's price target on Fabrinet to $739 from $702 and keeps an Overweight rating on the shares. The company posted a solid quarter, beating on sales and earnings, largely on data center strength, the analyst tells investors in a research note. However, the firm says Fabrinet's datacom and high performance compute missed estimates again in fiscal Q4. It believes the company's new capacity is on track and new programs are ramping to drive growth in fiscal 2027 and beyond.
  • VEEV Barclays raised the firm's price target on Veeva to $275 from $235 and keeps an Overweight rating on the shares ahead of the earnings report on August 26. The firm models 13%-14% normalized billings growth off an easier Crossix compare relative to Q1. Veeva's fiscal year guide "seems beatable," the analyst tells investors in a research note.
  • LEU Barclays initiated coverage of Centrus Energy with an Equal Weight rating and $207 price target. Th e company has historically been a broker of enriched nuclear fuel and uranium, selling foreign produced enriched uranium to American utilities looking to restock their power plants, and is now working its way towards enriching uranium itself, the analyst tells investors in a research note. Barclays says Centrus has a $2.4B backlog of enriched uranium and is the only company in the U.S. with the ability to commercially enrich high assay low enriched uranium.

BMO CAPITAL

  • IT BMO Capital lowered the firm's price target on Gartner to $206 from $214 and keeps a Market Perform rating on the shares. The firm notes that upon further review, it is adjusting its model following the company's results. Most quarter-end contract value applies to Insights, but a small portion goes to Conferences, so BMO slightly reduced Insights revenue assumptions as newer conferences added this year are smaller, the analyst tells investors in a research note. BMO adds that it may have been slightly aggressive regarding the company's future margin expansion.

BOFA

  • ENVX BofA lowered the firm's price target on Enovix to $5 from $8 and keeps a Neutral rating on the shares. The firm sees the resignation of CEO Raj Talluri as an "overhang on the stock that adds incremental uncertainty."
  • ATHM BofA analyst Miranda Zhuang downgraded Autohome to Underperform from Neutral with a price target of $19, down from $20.20. The company is facing "significant" earnings pressure from auto industry headwinds and its business transition, the analyst tells investors in a research note. The firm says Autohome has weaker financials and higher industry risk versus the other other China online vertical platforms. It sees the company's adjusted net profit declining 39% in 2026 and has lower visibility on Autohome's long-term growth.
  • NVDA BofA analyst Vivek Arya sees a "compelling" valuation for Nvidia at current share levels. The shares are trading at a 34%-50% free cash flow discount even when including the risks of its rising vendor financing, the analyst tells investors in a research note. The firm believes Nvidia's "off-balance-sheet risk matters but resists easy valuation." The shares at current levels "could be overstating the risks and creating a compelling opportunity," contends BofA. It expects Nvidia to provide more disclosure around its off balance sheet commitments on the August 26 earnings. The firm reiterates a Buy rating on the shares with a $350 price target.
  • COLD BofA analyst Samir Khanal upgraded Americold Realty Trust to Neutral from Underperform with a price target of $16, up from $15. Americold's Q2 results showed improvement in physical occupancy and throughput and increased its FY26 AFFO per share guidance by 4c at the midpoint, driven by first half outperformance and continued positive trends, the analyst tells investors in a research note. While fundamentals are stabilizing, demand remains soft, the firm says.
  • ARGX BofA analyst Tazeen Ahmad raised the firm's price target on Argenx to $1,136 from $1,088 and keeps a Buy rating on the shares. Argenx's positive Phase 3 ALKIVIA results de-risk efgartigimod's potential in myositis, with statistical significance in the INM subgroup supporting an 80% likelihood of success and $3.4B potential peak INM sales, while Sjogren's data in 2H27 and empasiprubart's MMN readout in Q4 are the next major catalysts, the analyst tells investors in a research note.
  • ZS BofA raised the firm's price target on Zscaler to $210 from $175 and keeps a Buy rating on the shares. Zscaler's outlook benefits from a more favorable valuation framework for AI-enabled security platforms and confidence in durable growth as enterprises adopt Zero Trust, cloud-native security, and AI-driven workflows, with its position across network transformation, data protection, and secure access reinforcing its strategic importance, the analyst tells investors in a research note.
  • S BofA raised the firm's price target on SentinelOne to $26 from $22 and keeps a Buy rating on the shares. SentinelOne's outlook is improving on broader AI-security multiple expansion, stronger execution, and its evolution into a broader platform, with Data, AI, and Cloud already contributing roughly half of annual recurring revenue and record net new ARR, improving large-customer trends, and progress toward profitable growth supporting the longer-term thesis, the analyst tells investors in a research note.
  • FERG BofA lowered the firm's price target on Ferguson to $315 from $325 and keeps a Buy rating on the shares. Ferguson offers positive earnings momentum, including volume outperformance, positive pricing and margin trends driven by inflation, upside from acquisitions and large cash returns to shareholders, the analyst tells investors in a research note.
  • HAE BofA analyst Travis Steed raised the firm's price target on Haemonetics to $120 from $100 and keeps a Buy rating on the shares. CSL Plastma's transition of select U.S. plasma centers to the latest-generation Haemonetics platform is a bullish productivity and efficiency catalyst, reinforcing Haemonetics' competitive and technology differentiation and potentially creating upside to Street estimates, the analyst tells investors in a research note.
  • HASI BofA lowered the firm's price target on HASI to $45 from $49 and keeps a Buy rating on the shares. HASI delivered a Q2 EPS beat and raised 2028 adjusted EPS guidance, with strong deployment, more than 11% new asset yields, wider investment margins, lower debt costs, and improved capital efficiency driving 31% year over year 1H26 adjusted earnings growth and ROE above 15%, the analyst tells investors in a research note.

CANACCORD

  • AORT Canaccord analyst William Plovanic raised the firm's price target on Artivion to $40 from $39 and keeps a Buy rating on the shares. The firm updated its model following the relrease of its !0-Q filing. The revenue stimates were adjusted to reflect the additional data in the filing.
  • LUNR Canaccord lowered the firm's price target on Intuitive Machines to $39 from $41 and keeps a Buy rating on the shares. The firm updated its model after Management reiterated its FY26 expectations, continuing to aim for midpoint revenue of $950M and a positive Adj. EBITDA.
  • SBET Canaccord analyst Joseph Vafi lowered the firm's price target on SharpLink Gaming to $8 from $19 and keeps a Buy rating on the shares. The firm said despite what's been a relatively difficult H1 for ETH, SharpLink continues to move along nicely, taking solid and differentiated strategic steps to move the company forward. Canaccord lowered its target to reflect a conservative move from its current mNAV to 1x mNAV.

CANTOR FITZGERALD

  • DUOT Cantor Fitzgerald raised the firm's price target on Duos Technologies to $27 from $26 and keeps an Overweight rating on the shares. Duos Technologies' latest $500M, five-year data-center lease for 55 MW lifts contracted capacity to 75 MW and should drive a sharp revenue and EBITDA inflection by 1Q27, the analyst tells investors in a research note.
  • AMGN Cantor Fitzgerald raised the firm's price target on Amgen to $400 from $350 and keeps a Neutral rating on the shares. The revised estimates better capture Amgen's near-term commercial outlook and largely support the recent share-price move, but the key question is whether a relatively narrow 2H26 late-stage pipeline, centered on Sjogren's and EoE, can sustain further momentum, the analyst tells investors in a research note.

CHARDAN

  • RANI Chardan initiated coverage of Rani Therapeutics with a Buy rating and $6 price target. The company offers is "best-in-class" among oral delivery platforms for injectable biologics, the analyst tells investors in a research note. The firm says RaniPill has demonstrated bioavailability comparable to subcutaneous dosing, building one of the more mature in-human datasets in the space.

CITI

  • BBWI Citi analyst Paul Lejuez upgraded Bath & Body Works to Buy from Neutral with an unchanged price target of $25. The firm sees a favorable risk/reward into the company's Q2 earnings report. Citi expects Bath & Body to report an earnings beat and offer positive commentary about recent product launches. The firm believes the recent Fruit Fusion launch is preforming well.
  • DT Citi raised the firm's price target on Dynatrace to $65 from $62 and keeps a Buy rating on the shares. Citi also added an "upside 90-day catalyst watch" on Dynatrace. Citi sees "lots to like" following the stock's recent underperformance. Dynatrace is on a path back to 20% annual recurring revenue growth and its investor day post the Q2 report amid activist involvement should be a catalyst for the shares, the analyst tells investors in a research note.
  • EYPT Citi lowered the firm's price target on EyePoint to $17 from $35 and keeps a Buy rating on the shares. The firm sees greater risk for the LUCIA stud given LUGANO's endpoint miss. However, Citi still sees a possible path forward for EyePoint in wet age-related macular degeneration.
  • NTAP Citi analyst Asiya Merchant raised the firm's price target on NetApp to $209 from $150 and keeps a Neutral rating on the shares ahead of the earnings report on September 2. The company is well positioned due to improving enterprise storage spend, the analyst tells investors in a research note. However, Citi sees a full valuation at current share levels.
  • CRM Citi raised the firm's price target on Salesforce to $204 from $187 and keeps a Neutral rating on the shares ahead of the Q2 earnings report. Citi's partner fieldwork remained mix on Salesforce but improved modestly from Q1, the analyst tells investors in a research note. The firm upped its Q2 sales estimates to match consensus on its better channel checks.

COMPASS POINT

  • GRRR Compass Point initiated coverage of Gorilla Technology with a Buy rating and $44 price target. Since March, the company has built an India and Indonesia commercial book totaling $5.5B, the analyst tells investors in a research note. The firm sees an "earnings inflection" for Gorilla, supported by the current commercial book and additional value potential as the company expands its capacity strategy.

DA DAVIDSON

  • DUOL DA Davidson analyst Wyatt Swanson upgraded Duolingo to Buy from Neutral with a price target of $160, up from $130. The company's marketing and core monetization changes are underappreciated at current share levels, the analyst tells investors in a research note. The firm sees a "long runway for growth" in the coming years for Duolingo. DA believes the company's daily active users can continue to accelerate and its bookings can converge with this growth. Duolingo "is nearing a turning point," the firm contends.

GOLDMAN SACHS

  • DK Goldman Sachs analyst Alexa Petrick raised the firm's price target on Delek US to $83 from $73 and keeps a Buy rating on the shares. The firm's outlook remains positive, supported by improving refining operations, robust cash-flow generation, and the upside optionality from small refinery exemptions, the analyst tells investors in a research note.
  • C
  • PBF Goldman Sachs raised the firm's price target on PBF Energy to $81 from $71 and keeps a Neutral rating on the shares. The firm's outlook remains constructive given strong leverage to refining margins and continued deleveraging, with net debt-to-capital reduced to about 15% in Q2, though valuation and operational execution remain key considerations, the analyst tells investors in a research note.

GUGGENHEIM

  • MDB Guggenheim raised the firm's price target on MongoDB to $560 from $475 and keeps a Buy rating on the shares. MongoDB is set up for a potentially strong F2Q27 beat-and-raise, with expected Atlas growth of 29%, F3Q guidance around 26%, and FY27 revenue growth potentially raised toward 22%, while accelerating AI/agentic-app adoption, new product capabilities, strong hyperscaler capacity prebuys, and improving consumption support further Atlas acceleration into FY28, the analyst tells investors in a research note.

JEFFERIES

  • TRGP Jefferies analyst Julien Dumoulin-Smith raised the firm's price target on Targa Resources (TRGP) to $345 from $324 and keeps a Buy rating on the shares. The company's expanded agreement with Exxon Mobil (XOM) adds three Delaware processing plants in the firs half of 2028 and further strengthens its visibility into sustained growth above basin averages, the analyst tells investors in a research note. Jefferies upped its EBTDA estimates for Targa well above consensus following the news.
  • OKTA Jefferies raised the firm's price target on Okta to $170 from $140 and keeps a Buy rating on the shares as part of an earnings preview. The firm expects Okta to beat its Q2 remaining performance obligation guidance of $2.51B by 2%. The shares have re-rated but remain attractive, the analyst tells investors in a research note. Jefferies sees high investor expectations into Okta's quarter.

JPMORGAN

  • NUVB JPMorgan initiated coverage of Nuvation Bio with an Overweight rating and $13 price target. The company's launch of Ibtrozi in non-small cell lung cancer is showing durable and growing first-line adoption, the analyst tells investors in a research note. The firm says genetic sequencing could make the revenue opportunity more prevalence-driven over time. JPMorgan views Nuvation Bio shares as undervalued.
  • AMX JPMorgan upgraded America Movil to Overweight from Neutral with a price target of $32, up from $30. The company's operating trends are "very solid," the analyst tells investors in a research note. The firm says America Movil's prepaid mobile has accelerated for five consecutive quarters, suggesting a better competitive backdrop than broader consumer indicators would imply and easing concerns around Walmex's Bait.
  • TIGO JPMorgan analyst Marcelo Santos downgraded Millicom to Neutral from Overweight with a price target of $105, up from $100. The firm cites increased expectations for the downgrade. Consensus estimates have mostly incorporated Millicom's consolidation benefits expected from the Colombian consolidation, the analyst tells investors in a research note. JPMorgan would wait would for more visibility on the company's Chilean operations and potential acquisitions in Peru or Venezuela before buying the shares.
  • FN JPMorgan raised the firm's price target on Fabrinet to $695 from $680 and keeps a Neutral rating on the shares post the fiscal Q4 report. The company's soft datacom and high performance compute belies its accelerating revenue growth outlook, the analyst tells investors in a research note.

KEYBANC

  • KRG KeyBanc last night downgraded Kite Realty to Sector Weight from Overweight without a price target. The company has executed well on leasing, portfolio enhancement, and capital allocation, the analyst tells investors in a research note. However, the firm believes much of Kite's progress is reflected in shares at current levels. It expects the stock to perform more in line with peers going forward.
  • AKR KeyBanc last night upgraded Acadia Realty Trust to Overweight from Sector Weight with a $25 price target. The stock's underperformance year-to-date versus the shopping center real estate investment trust group has created an attractive entry point, the analyst tells investors in a research note. The firm sees improving visibility for Acadia around several of its earnings growth drivers, including a growing signed not open pipeline, additional Street and Urban lease-up, City Point value creation, and continued capital deployment.

LADENBURG

  • EDIT Ladenburg initiated coverage of Editas Medicine with a Buy rating and $6 price target.

MIZUHO

  • NCLH Mizuho downgraded Norwegian Cruise Line to Neutral from Outperform with a price target of $17, down from $22. The company is undergoing a turnaround amid "self-inflicted wounds" from accelerated supply, change in customer segmentation, and delays in construction, as well as macro headwinds, the analyst tells investors in a research note. Mizuho is positive on the cruise sector and believes Norwegian will successfully emerge from its turnaround. However, the firm thinks the shares could trade sideways for the next 6-12 months and offer opportunities to accumulate at lower prices given an uncertain medium-term outlook and potential downside to Street estimates.

MORGAN STANLEY

  • METC Morgan Stanley lowered the firm's price target on Ramaco Resources to $11 from $13 and keeps an Equal Weight rating on the shares. Ramaco is shifting focus at its Brook Mine away from rare earths and scandium toward semiconductor-critical minerals, with the project now included only in the bull case, the analyst tells investors in a research note.
  • FSLR Morgan Stanley raised the firm's price target on First Solar to $323 from $245 and keeps an Overweight rating on the shares. The bullish Section 232 tariff outcome improves pricing power and visibility, supporting higher long-term EPS estimates and a higher price target, with accelerating bookings, stronger price realization from 2028 onward, and renewed order visibility providing further upside, the analyst tells investors in a research note.
  • LTH Morgan Stanley analyst Stephen Grambling raised the firm's price target on Life Time Group to $53 from $39 and keeps an Overweight rating on the shares. Life Time delivered Q2 results above expectations on membership growth, comps, and margins, supporting a higher price target and valuation multiple given its potential to sustain 15%-16% EBITDA growth over the next three years, the analyst tells investors in a research note.
  • PLNT Morgan Stanley raised the firm's price target on Planet Fitness to $51 from $47 and keeps an Equal Weight rating on the shares. Planet Fitness estimates rise on the Q2 beat, share repurchases, and equipment revenue, but visibility into pricing and volume remains limited given the planned $10 national promotion in Q3 and a year-end marketing reset, the analyst tells investors in a research note.

NEEDHAM

  • LULU Needham analyst Tom Nikic keeps a Hold rating with no price target on Lululemon ahead of the company's Q2 results in early September. Demand remains challenged, athletic names have had a tough EPS season, and the pending CEO change adds to the uncertainty, the analyst tells investors in a research note. Needham adds that it remains on the sidelines despite valuation metrics on Lululemon shares being at their lowest level in years.

RAYMOND JAMES

  • ANF Raymond James downgraded Abercrombie & Fitch to Market Perform from Outperform without a price target. The firm cites valuation for the downgrade with the shares up 25% since the Q1 results. Raymond James sees a balanced risk/reward with the stock around $105. The firm expects Abercrombie same-store-sales to remain mixed and says its channel checks indicated quarter-over-quarter softness, which limits its near-term confidence in estimates.

RBC CAPITAL

  • EYPT RBC Capital last night downgraded EyePoint to Sector Perform from Outperform with a price target of $5, down from $37. The LUGANO study missed its primary non-inferiority endpoint, which is negative for the shares, the analyst tells investors in a research note. RBC thinks it will take time for EyePoint to clear the clinical and regulatory overhang created from the LUGANO study. Even if the LUCIA study has positive results, questions will remain whether Duravyu is having a negative impact on vision in certain segments of the patient population, and whether the FDA will approve based on LUCIA alone, contends RBC.

STEPHENS

  • MYGN Stephens lowered the firm's price target on Myriad Genetics to $3 from $5 and keeps an Equal Weight rating on the shares. Myriad Genetics' shares fell more than 40% after a 7% Q2 revenue miss, a $90M reduction to FY26 revenue guidance, and suspension of adjusted EBITDA guidance, with payer friction in Hereditary Cancer Testing and slower Prenatal volume recovery likely to pressure near-term performance and sentiment, the analyst tells investors in a research note.

STIFEL

  • ESTC Stifel raised the firm's price target on Elastic to $90 from $65 and keeps a Buy rating on the shares. Off-calendar software companies are expected to post strong Q2 results,but recent outperformance may already reflect much of the upside, the analyst tells investors in a research note.
  • MDB Stifel raised the firm's price target on MongoDB to $475 from $435 and keeps a Buy rating on the shares. Off-calendar software companies are expected to post strong Q2 results,but recent outperformance may already reflect much of the upside, the analyst tells investors in a research note.
  • SNOW Stifel analyst Brad Reback raised the firm's price target on Snowflake to $350 from $300 and keeps a Buy rating on the shares. Off-calendar software companies are expected to post strong Q2 results,but recent outperformance may already reflect much of the upside, the analyst tells investors in a research note.

SUSQUEHANNA

  • HGV Susquehanna initiated coverage of Hilton Grand Vacations with a Neutral rating and $50 price target.
  • TNL Susquehanna initiated coverage of Travel + Leisure with a Positive rating and $95 price target.
  • VAC Susquehanna analyst Christopher Stathoulopoulos initiated coverage of Marriott Vacations with a Neutral rating and $110 price target.

TRUIST

  • CORT Truist assumed coverage of Corcept Therapeutics with a Buy rating with a price target of $164, up from $50. The form is positive on the company's opportunity in Cushing's, which continues to be a backbone of Corcept valuation, and Truist anticipates relacorilant approval and broader adoption given its differentiated profile, the analyst tells investors in a research note. The firm adds that Corcept's Lifyorli, with early approval and strong early launch in ovarian cancer, also presents a blockbuster opportunity.
  • ARGX Truist analyst Danielle Brill raised the firm's price target on Argenx to $1,095 from $1,030 and keeps a Buy rating on the shares. The firm is boosting its price target to reflect the company's positive phase 3 top-line results with efgar in myositis. The data support an expedited approval in IMNM, or immune-mediated necrotizing myopathy, and while the timing of a DM approval remains dependent on regulatory discussions, the firm is increasingly confident that efgar will ultimately be successfully developed in this myositis subtype as well, the analyst tells investors in a research note.

UBS

  • SNOW UBS raised the firm's price target on Snowflake to $425 from $370 and keeps a Buy rating on the shares. Snowflake's pre-Q2 checks indicate accelerating AI-driven demand, with customers increasing data layer spending and CoCo adoption, while limited evidence of LLMs displacing data software spend supports the Buy thesis despite elevated expectations and competitive pressure from Databricks, the analyst tells investors in a research note.
  • NCLH UBS raised the firm's price target on Norwegian Cruise Line to $20 from $17 and keeps a Neutral rating on the shares. Norwegian Cruise Line is attributing recent weakness primarily to execution, particularly at the Norwegian brand, and is resetting expectations for a longer turnaround, with its revised pricing strategy unlikely to produce visible benefits until 2H27 and 1H27 yields still expected to decline, the analyst tells investors in a research note.
  • CTVA UBS analyst Joshua Spector lowered the firm's price target on Corteva to $85 from $89 and keeps a Neutral rating on the shares. Corteva has a more favorable setup into its September 15 investor days and October 1 spin, with the post-earnings reset lowering expectations and creating greater potential for upside surprises despite a potentially slower-growth 2027, the analyst tells investors in a research note.

WELLS FARGO

  • IRTC Wells Fargo lowered the firm's price target on iRhythm to $168 from $180 and keeps an Overweight rating on the shares. The firm cites the Q2 sales and margins beat and raised guidance. Wells also notes that while not fully clear on the entire strategy behind the VitalConnect deal, at about three or four times its forward sales estimates, the deal price "isn't egregious."

WILLIAM BLAIR

  • ELVN William Blair initiated coverage of Enliven with an Outperform rating. The company is advancing ELVN-001, a "highly selective and efficacious" tyrosine kinase inhibitor for chronic myeloid leukemia, the analyst tells investors in a research note. The firm says "clear regulatory precedent and historical reproducibility of early-stage clinical data de-risk the commercial potential of ELVN-001."

Rating abbreviations…

***OP = Outperform

***SP = Sector Perform

***UP = Underperform

***OW = Overweight

***EW = Equal-weight

***UW = Underweight

 

 

 

 

***Report powered by thefly.com***

What’s on Tap Weekly Calendar

 

Monday August 17th

Economic Calendar: 

  • 8:30 AM ET NY Empire Manufacturing for August
  • 10:00 AM ET NAHB Housing Market Index for August
  • 4:00 PM ET                    Net Long-term TIC Flows for June

Earnings Calendar:

  • Earnings Before the Open: FUFU HTHT NSPR
  • Earnings After the Close: DCGO FLXS FN XP YALA

Other Key Events:

  • Needham 15th annual Virtual Industrial Tech Robotics & Power 1x1 Conference, 8/18-8/18
  • Rosenblatt 6th Annual Age of AI Tech Virtual Summit, 8/17-8/18

Tuesday August 18th

Economic Calendar: 

  • 7:45 AM ET ICSC Weekly Retail Sales
  • 8:30 AM ET                   Housing Starts M/M for July
  • 8:30 AM ET                   Building Permits M/M for July
  • 8:30 AM ET                   Import Prices M/M for July
  • 8:30 AM ET                   Export Prices M/M for July
  • 8:55 AM ET                   Johnson/Redbook Weekly Sales
  • 9:15 AM ET                   Industrial Production M/M for July
  • 9:15 AM ET                   Capacity Utilization for July
  • 10:00 AM ET                 Pending Home Sales M/M for July
  • 4:30 PM ET API Weekly Inventory Data

Earnings Calendar:

  • Earnings Before the Open: AS BIDU EVGN HD HSAI IQ KLAR PONY PRE UCL VNET
  • Earnings After the Close: AUNA JKHY KEYS LZB MRCY SQM TOL ZTO

Other Key Events:

  • Needham 15th annual Virtual Industrial Tech Robotics & Power 1x1 Conference, 8/18-8/18
  • Piper California Medtech & Diagnostics Bus Tour, 8/18-8/20
  • Rosenblatt 6th Annual Age of AI Tech Virtual Summit, 8/17-8/18
  • Seaport Global 15th Annual Summer Investor Virtual Conference, 8/18-8/19

Wednesday August 19th

Economic Calendar: 

  • 7:00 AM ET MBA Mortgage Applications Data
  • 10:30 AM ET                 Weekly EIA Inventory Data
  • 1:00 PM ET US Treasury to sell $13B in 20-year bonds

Earnings Calendar:

  • Earnings Before the Open: ADI AIB DVLT EL FLNG KC LOW OPRA TGT TJX TOYO VIK WB YMM ZIM
  • Earnings After the Close: ARAY BILL ALVO BULL COTY NDSN TLX UFI WOLF

Other Key Events:

  • Cantor Internet Bus Tour, 8/19 in San Francisco
  • Needham 7th Annual Virtual Semiconductor & Semicap 1x1 Conference, 8/19-8/20
  • Piper California Medtech & Diagnostics Bus Tour, 8/18-8/20
  • Seaport Global 15th Annual Summer Investor Virtual Conference, 8/18-8/19

Thursday August 20th

Economic Calendar: 

  • 8:30 AM ET                   Weekly Jobless Claims
  • 8:30 AM ET                   Continuing Claims
  • 8:30 AM ET                   Philly Fed Business Index for August
  • 10:00 AM ET                 Leading Indicators M/M for July
  • 10:30 AM ET                 Weekly EIA Natural Gas Inventory Data

Earnings Calendar:

  • Earnings Before the Open: AAP ATAT ATHM BABA DAO DE DQ FLX FUTU HOV LYTS NTES RERE SCSC TWIN WMT
  • Earnings After the Close: FLO FLUX ICG OSIS ROST

Other Key Events:

  • B Riley Virtual Space & Defense Technologies Symposium, 8/20
  • Needham 7th Annual Virtual Semiconductor & Semicap 1x1 Conference, 8/19-8/20
  • Piper California Medtech & Diagnostics Bus Tour, 8/18-8/20

Friday August 21st

Economic Calendar: 

  • 9:45 AM ET S&P Global Manufacturing PMI, Aug-flash
  • 9:45 AM ET S&P Global Services PMI, Aug-flash
  • 9:45 AM ET S&P Global Composite PMI, Aug-flash
  • 1:00 PM ET                    Baker Hughes Weekly rig count data

Earnings Calendar:

  • Earnings Before the Open: BEKE BJ BKE ZKH

 

 

.

As a value-added service exclusive to Regal Securities account holders, The Hammerstone Report is available to read daily on the trading platform.

Hammerstone Inc. (the “Report”) provides information and data and does NOT provide any individual investment advice or money management assistance and does NOT attempt to influence the sale or purchase of securities. The Report is intended for informational purposes only and does not claim to be actionable for investment decisions. The information contained in the Report has been obtained from sources deemed to be reliable but is not represented to be complete, and it should not be relied upon as such. The Report does not purport to be a complete analysis of any security, issuer, or industry and is not an offer or a solicitation of an offer to buy or sell any securities. The Report is prepared for general information purposes only and does not consider the specific investment objectives, financial situation, and particular needs of any individual subscriber, person, or entity.

Content is provided for educational and informational purposes only and Regal Securities cannot attest to its accuracy or completeness. No information provided has been endorsed by Regal Securities and does not constitute a recommendation by Regal Securities to buy or sell a particular investment. You are solely responsible for your own investment decisions and Regal Securities makes no investment recommendations and does not provide financial, tax, or legal advice. Regal Securities may provide links to internet sites maintained by third parties. Unless expressly stated otherwise, links in these reports are not sponsored by nor are they the responsibility of Regal Securities. Regal Securities has not verified the content, accuracy, or opinions expressed on any links in these reports and disclaims any warranty or liability for damages associated therewith.

Copyright 2006-2026 Regal Securities, Inc., Member FINRA/SIPC | Important Disclosures

Your privacy is important to us; see our Privacy Policy for details.

Regal Securities, 950 Milwaukee Ave., Ste. 102, Glenview, IL 60025
Website: www.regalsecurities.com | Toll-free: 1-877-488-6534
Representatives are available Monday through Friday from 8:00 a.m. to 5:00 p.m. EST.